Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Problem with the Share Price

You wrote: one thing is certain, which is that the situation wasn't produced by the retail shareholders.

Actually it could be argued that it was produced by the retail shareholders because they should have voted the current board out long ago. But then to paraphrase one of the current board, " they had their chance".

I would add that the retail shareholders still have a chance to remove the current board, just like the current board still has a chance to raise the share price and redeem themselves.

Share
New Message
Please login to post a reply